network. experience. benefit.

ECA - Barrier Systems

24./25. April 2018


Reasons to attend this conference:

  • Case studies from various pharmaceutical companies deal with the implementation, qualification and operation of Isolator and RABS systems.
  • You will discuss the current state of the art and new technological developments in Barrier Systems technology.
  • You will get to know first hand the new EU-GMP Annex 1 draft requirements on Barrier Systems.
  • Experts from pharmaceutical companies will share their knowledge regarding operational experience.



  • Barrier Systems and EU GMP Annex 1:
    • Inspector’s point of view
    • Industry’s point of view
    • PhSS perspective
  • Case Studies from
    • Hydro-Fill
    • Boehringer Ingelheim Pharma
    • Cilag
    • GSK Vaccines
    • Novartis
    • Orient Pharma Nano
    • Sanofi Pasteur
    • Vetter Pharma-Fertigung



  • Dr. Patricia Desmaris, Sanofi Pasteur
  • James Drinkwater, The Pharmaceutical & Healthcare Sciences Society
  • Dr. Friedrich Haefele, Boehringer Ingelheim Pharma
  • Dr. Lars Kreye, Boehringer Ingelheim Pharma
  • Didier Meyer, DMCompliance
  • Dr. Daniel Müller, GMP Inspector, Local Authority of Baden Württemberg
  • Tobias Schlögl, Vetter Pharma-Fertigung
  • Dr. Andreas Schreiner, Novartis Pharma
  • Roland Schuhwerk, Johnson & Johnson / Cilag
  • Calvin Tsai, Orient Pharma Co
  • Patrick Vanhecke, GSK Vaccines
  • Dr. Jean-Pascal Zambaux, Hydro-Fill


Regulatory Trends


PDF der ECA-Konferenz Barrier Systems

Informieren Sie sich auch über den zeitlichen Ablauf im Gesamtzeitplan.